Clinical Trial Update: Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating validation of usage instructions for TOBI Podhaler in cystic fibrosis; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• TOBI Podhaler (tobramycin inhalation powder)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Cystic Fibrosis | Phase 4 | Status: COMPLETED | Results posted: 2016-05-23